Healthcare Global Enterprises Limited

rs,

Mumbai - 400051, Maharashtra, India BSE Limited, Compliance Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400001, Maharashtra, India Dear Sir/Madam, Subject : Investor Presenta

rs1

Largest Pan-India Oncology Hospital Chain 2 22 4* 6 Center of Excellence (CoE) Cancer Care Centers1 Multi-specialty hospitals Day care centers Jaipur Ahmedabad Indore Ranchi Rajkot Bhavnagar B

55%

ngole Suchirayu Hubli Shimoga Vijaywada Kenya Bangalore LARGEST GEOGRAPHICAL REACH… 10 19 ~55% Number of states covered5 Number of cities covered5 Addressable market3 (population) 25 16/1

16.9%

R E V E N U E - H C G C e n t e r s ( 1 ) R E V E N U E - M i l a n n C e n t e r s Rs in M n +16.9% 6,470 5,535 +17.6% 6,322 5,378 -6.2% 158 148 Q2FY25 Q2FY26 Q2FY25 Q2FY26 Q2FY25 Q2FY2

17.6%

G C e n t e r s ( 1 ) R E V E N U E - M i l a n n C e n t e r s Rs in M n +16.9% 6,470 5,535 +17.6% 6,322 5,378 -6.2% 158 148 Q2FY25 Q2FY26 Q2FY25 Q2FY26 Q2FY25 Q2FY26 A d j u s t e d E B

6.2%

R E V E N U E - M i l a n n C e n t e r s Rs in M n +16.9% 6,470 5,535 +17.6% 6,322 5,378 -6.2% 158 148 Q2FY25 Q2FY26 Q2FY25 Q2FY26 Q2FY25 Q2FY26 A d j u s t e d E B I T D A * A d j u s

18.4%

F I T A F T E R T A X ( P r e - I N D A S ) P R O F I T A F T E R T A X ( P o s t - I N D A S ) +18.4% 24 bps -8.2% -9.6% 1,042 1,233 18.8% 19.1% 217 199 180 163 Q2FY25 Q2FY26 Q2FY25 Q2FY

24 bps

A F T E R T A X ( P r e - I N D A S ) P R O F I T A F T E R T A X ( P o s t - I N D A S ) +18.4% 24 bps -8.2% -9.6% 1,042 1,233 18.8% 19.1% 217 199 180 163 Q2FY25 Q2FY26 Q2FY25 Q2FY26 Q2FY

8.2%

T A X ( P r e - I N D A S ) P R O F I T A F T E R T A X ( P o s t - I N D A S ) +18.4% 24 bps -8.2% -9.6% 1,042 1,233 18.8% 19.1% 217 199 180 163 Q2FY25 Q2FY26 Q2FY25 Q2FY26 Q2FY25 Q2F

9.6%

( P r e - I N D A S ) P R O F I T A F T E R T A X ( P o s t - I N D A S ) +18.4% 24 bps -8.2% -9.6% 1,042 1,233 18.8% 19.1% 217 199 180 163 Q2FY25 Q2FY26 Q2FY25 Q2FY26 Q2FY25 Q2FY26 Q2

18.8%

) P R O F I T A F T E R T A X ( P o s t - I N D A S ) +18.4% 24 bps -8.2% -9.6% 1,042 1,233 18.8% 19.1% 217 199 180 163 Q2FY25 Q2FY26 Q2FY25 Q2FY26 Q2FY25 Q2FY26 Q2FY25 Q2FY26 1. Exc

19.1%

O F I T A F T E R T A X ( P o s t - I N D A S ) +18.4% 24 bps -8.2% -9.6% 1,042 1,233 18.8% 19.1% 217 199 180 163 Q2FY25 Q2FY26 Q2FY25 Q2FY26 Q2FY25 Q2FY26 Q2FY25 Q2FY26 1. Excluding

“Although the Company believes that such forward‐looking statements are based on reasonable assumptions, it can give no assurance that such expectations will be met.”

“c o m 4 Q2 &H1 FY26 FINANCIAL & OPERATIONAL HIGHLIGHTS SUBASENI LENKA, CANCER WINNER I am eternally thankful to Dr.”

“Excluding Fertility Business *Adjusted for ESOP H1’25: INR 38.5 Mn; H1’26: INR 14.5 Mn and one-off Q1 FY26 cost INR 25.6 Mn Lower PAT on account of higher depreciation and interest expense from growth investments and acquisitions undertaken in the last year www.hcgoncology.com www .”

“No 1 2 Particulars Capex incurred till 30 th September 2025 Total Planned Capex Expected Operational period North Bangalore Whitefield (Extension of Bangalore - COE) 452 137 1,290 290 Q4 FY26 FY27 1.”

“c o m 14 Q2 & H1 FY26 Consolidated Profit & Loss Account Profit and Loss (in Rs.”

Subject

1

Subject

Investor Presentation Stock Code : BSE – 539787, NSE – HCG This is to inform that the Board of Directors of the Company, at their meeting held today i.e., November 12, 2025, inter alia, has approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and six months ended September 30, 2025, (“Financial Results”). We enclose herewith the Presentation on the Financial Results of the Company. Request you to take this on record. Thanking you, For HealthCare Global Enterprises Limited Sunu Manuel Company Secretary & Compliance Officer Encl: a/a. HEALTHCARE GLOBAL ENTERPRISES LIMITED SAFE HARBOR This presentation and its contents are confidential and are not for release, publication or distribution, in whole or in part, directly or indirectly, in or into or from the United States of America, Canada, Australia, Japan or any jurisdiction where such distribution is unlawful. This presentation has been prepared by HealthCare Global Enterprises Limited (th